Alinity m HR HPV Assay
Cervical Cancer Screening
Key Facts
Indication
Cervical Cancer Screening
Phase
Commercial Launch
Status
Active (Recent FDA Approval)
Company
About Abbott
Abbott Laboratories is a diversified healthcare giant with a mission to advance human health through accessible, innovative solutions across the care continuum. Its strategic achievements are anchored in market-leading franchises like the FreeStyle Libre continuous glucose monitoring system and the Alinity diagnostic platform, driving consistent growth. The company's strategy balances deep R&D investment in high-growth areas like diabetes and cardiovascular care with a disciplined focus on operational efficiency and geographic expansion, particularly in emerging markets. This approach has solidified its position as a mature, financially robust enterprise with a $179.44B market capitalization.
View full company profileTherapeutic Areas
Other Cervical Cancer Screening Drugs
| Drug | Company | Phase |
|---|---|---|
| SureView Cervical Cytology System | Techcyte | Commercial |
| ScreenYu Gyn® | Epitype | Unknown |
| Vitro HPV Screening Assay | Appolon Bioteck | Approved/Commercial |
| Aptima® HPV Assay Primary Screening | Hologic | FDA Approved |